Ritalin (methylphenidate) for adults: what the FDA label says

Ritalin is the brand name most people connect with methylphenidate, one of the two main stimulant families used for ADHD. The name now covers more than one product, and their FDA labels do not all say the same thing about adults. This page goes through the immediate-release tablets, the older sustained-release tablets and Ritalin LA capsules, using the current labels on DailyMed (checked October 19, 2026). It describes what the labels say. It does not give doses, and it is not advice to start, stop or change any medication.

What methylphenidate is

Methylphenidate is a central nervous system (CNS) stimulant. The FDA labels say plainly that the way it helps ADHD "is not known." Some methylphenidate labels add that it blocks the reuptake of two brain chemicals, norepinephrine and dopamine, and increases their release. Methylphenidate is a Schedule II controlled substance, the same federal category as the amphetamine products. For a wider view of how the stimulant classes work, see how ADHD medications work.

Which Ritalin products are approved for adults

The short version: the classic immediate-release tablet is approved for adults, and so are the generic extended-release tablets that replaced Ritalin-SR. Ritalin LA is not. Its label limits the ADHD indication to children aged 6 to 12, so prescribing it to an adult is off-label use. Off-label prescribing is legal and sometimes reasonable, but it means the FDA did not review that use, and it is fair to ask a prescriber why that product was chosen.

Immediate-release tablets

Ritalin tablets are now marketed by Sandoz. The adult section of the dosing instructions describes taking the medicine two or three times a day, preferably 30 to 45 minutes before meals. That schedule is why immediate-release methylphenidate is usually described as short-acting. Many generic methylphenidate tablets carry the same adult wording.

Sustained-release tablets (the old Ritalin-SR)

FDA's Drugs@FDA database lists brand Ritalin-SR as discontinued. Generic methylphenidate extended-release tablets of this older type remain on the market, and the label checked for this guide says they must be swallowed whole and never crushed or chewed. These are different from the osmotic once-daily tablets sold as Concerta, which are covered in Concerta for adults.

Ritalin LA capsules

Ritalin LA is a once-daily capsule that may be swallowed whole or opened and sprinkled on applesauce, according to its label. Its indication is ADHD "in pediatric patients 6 to 12 years of age." Adults who see "Ritalin" on a prescription should check which product it is, because the brand name alone does not tell you whether the label covers your age.

The boxed warning

Every Ritalin label opens with a boxed warning titled "Abuse, Misuse, and Addiction." It says methylphenidate has a high potential for abuse and misuse that can lead to a substance use disorder, including addiction, and that misuse can result in overdose and death, especially at higher doses or by snorting or injection. Prescribers are told to assess each patient's risk before prescribing and to keep reassessing it. The FDA required this updated wording across all prescription stimulants in May 2023.

Common side effects in the label

The Ritalin label lists reactions reported with methylphenidate rather than a percentage table. Among them are decreased appetite, trouble sleeping (insomnia), anxiety, restlessness, headache, dizziness, nausea and abdominal pain. Methylphenidate products studied in adult trials, such as Concerta, list decreased appetite, headache, dry mouth, nausea, insomnia, anxiety, dizziness, weight loss, irritability, fast heart rate and sweating as the most common. The guide page on side effects in adults explains which ones call for a phone call to the prescriber.

Warnings worth knowing

• Heart and blood pressure: the label advises avoiding use in people with known serious heart disease and monitoring blood pressure and pulse. See ADHD medication, heart health and blood pressure.
• Mental health: prescribers should screen for risk factors for mania before starting, and new psychotic or manic symptoms are a reason to reconsider treatment.
• Circulation: fingers or toes that turn pale, cold or painful (Raynaud's phenomenon) should be reported.
• Priapism: a prolonged, painful erection needs immediate medical attention.
• Eyes: warnings cover acute angle closure glaucoma and raised eye pressure.
• Tics: methylphenidate can bring on or worsen tics and Tourette's syndrome.

Who should not take it

The label lists two contraindications: an allergy (hypersensitivity) to methylphenidate or another ingredient, and taking a monoamine oxidase inhibitor (MAOI) now or within the past 14 days, because the combination can cause a hypertensive crisis.

Interactions to mention to your prescriber

• MAOIs (see above).
• Blood pressure medicines: methylphenidate may make them less effective.
• Surgery: the label says to avoid methylphenidate on the day of surgery when halogenated anesthetics are used.
• Risperidone: changing the dose of either drug may raise the risk of movement side effects.
• Serotonergic drugs: serotonin syndrome in combination with these drugs appears among reported reactions.

A full list across ADHD medications is in ADHD medication drug interactions.

Pregnancy and breastfeeding

The Ritalin label says published studies and postmarketing reports have not identified a drug-associated risk of major birth defects, miscarriage or other adverse outcomes, while noting that stimulants can narrow blood vessels and reduce blood flow to the placenta. It points to the National Pregnancy Registry for ADHD Medications. For breastfeeding, the label says methylphenidate passes into human milk and advises watching the infant for agitation, poor sleep, poor feeding and reduced weight gain. The National Library of Medicine's LactMed database summarizes the research. The article on ADHD in pregnancy and postpartum covers the larger studies.

What the evidence says for adults

A 2018 network meta-analysis in Lancet Psychiatry found that methylphenidate reduced adult ADHD symptoms more than placebo at about 12 weeks, alongside amphetamines and atomoxetine. The UK's NICE guideline recommends offering lisdexamfetamine or methylphenidate as first-line medication for adults with ADHD. How methylphenidate compares with amphetamine is covered in methylphenidate vs amphetamine and Adderall vs Ritalin.

Generics, cost and supply

Immediate-release methylphenidate tablets and extended-release tablets are sold by many generic manufacturers, and the generic labels checked for this guide carry the same adult indication as the brand. As of mid-October 2026, FDA's drug shortage database listed methylphenidate extended-release among current shortages. A pharmacy can tell you what it has in stock, and what to do during a shortage lists the lawful options.

New York and New Jersey rules

Because methylphenidate is Schedule II, both states apply their strictest prescription rules. In New York, a prescription is limited to a 30-day supply unless the prescriber writes for a condition the state allows up to three months for, attention deficit disorder among them, and Schedule II prescriptions cannot be refilled. See New York's rules for ADHD stimulant prescriptions. In New Jersey, each prescription covers up to 30 days, and a prescriber may issue several dated prescriptions covering up to 90 days. Since July 8, 2026, adults located in New Jersey who start a Schedule II stimulant by telehealth need an in-person visit within 30 days. Details are in New Jersey's ADHD medication rules.

Questions to ask your prescriber

• Which methylphenidate product is this, and does its label cover adults?
• Is an immediate-release tablet, an extended-release tablet or a once-daily product a better fit for my workday?
• How will my blood pressure and heart rate be checked?
• Which of my other medicines or supplements could interact with it?
• What should I do if my pharmacy cannot fill it?

Dr. Shershow evaluates adults for ADHD and, when medication is appropriate, manages it with ongoing follow-up. Learn more about adult ADHD treatment.